A Patient of Using Presepsin to Diagnose Streptococcal Toxic Shock Syndrome during Anticancer Drug Treatment
Background. Streptococcal toxic shock syndrome (STSS) is a rapidly progressive infection, with potentially rapid patient deterioration in a very short period. We experienced a rare case of STSS during anticancer chemotherapy, and we continuously measured presepsin (P-SEP) and evaluated its usefulnes...
Saved in:
| Main Author: | Gaku Takahashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Critical Care |
| Online Access: | http://dx.doi.org/10.1155/2019/3240501 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resurgence of Virulent Group A Streptococcal Infections – The Streptococcal Toxic Shock Syndrome
by: JM Conly, et al.
Published: (1992-01-01) -
Emerging Trends in Streptococcal Toxic Shock Syndrome, Japan
by: Mugen Ujiie
Published: (2025-04-01) -
Comparative analysis of streptococcal toxic shock syndrome caused by three β-hemolytic streptococcal species in Japan
by: Yuuki Tsuchihashi, et al.
Published: (2025-09-01) -
Prognostic factors for streptococcal toxic shock syndrome: systematic review and meta-analysis
by: Lehana Thabane, et al.
Published: (2022-12-01) -
Group A Streptococcal Toxic Shock Syndrome after a Routine Gynecological Procedure
by: Kei Ameda, et al.
Published: (2021-01-01)